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LiverThe transcription factor Gata4 is essential for normal heart morphogenesis and regulates the survival,
growth, and proliferation of cardiomyocytes. We tested if Gata4 can specify cardiomyocyte fate from an
uncommitted stem or progenitor cell population, by developing a system for conditional expression of Gata4
in embryonic stem cells. We ﬁnd that in embryoid body cultures containing even a low ratio of these cells,
expression of Gata4 is sufﬁcient to enhance signiﬁcantly the generation of cardiomyocytes, via a non-cell-
autonomous mechanism. The Gata4-expressing cells do not generate cardiac or other mesoderm derivatives.
Rather, Gata4 expression directs the development of two types of Sox17+ endoderm. This includes an
epCam+Dpp4+ subtype of visceral endoderm. In addition, Gata4 generates similar amounts of epCam+
Dpp4− deﬁnitive endoderm enriched for Cxcr4, FoxA2, FoxA3, Dlx5 and other characteristic transcripts. Both
types of endoderm express cardiac-inducing factors, including WNT antagonists Dkk1 and Sfrp5, although
the visceral endoderm subtype has much higher cardiac-inducing activity correlating with relatively
enhanced levels of transcripts encoding BMPs. The Gata4-expressing cells eventually express differentiation
markers showing commitment to liver development, even under conditions that normally support
mesoderm development. The results suggest that Gata4 is capable of specifying endoderm fates that
facilitate, with temporal and spatial speciﬁcity, the generation of cardiomyocyte progenitors from associated
mesoderm.
© 2009 Elsevier Inc. All rights reserved.Introduction
Understanding the transcriptional and signaling programs that
specify cardiomyocyte fate from uncommitted progenitors may
provide important clues to impact cellular strategies for treating
failing or infarcted heart tissue. GATA factors comprise a small family
of highly conserved zinc ﬁnger transcription factors that play critical
roles in the development of the cardiovascular, hematopoietic,
digestive, and reproductive systems (Patient and McGhee, 2002).
Based on its expression in early precardiac mesoderm, and the pheno-
types caused by various gain- and loss-of-function experiments,
Gata4 is considered a key regulator of cardiogenesis (Pikkarainen
et al., 2004). Indeed, mutations in the Gata4 gene cause human
congenital cardiomyopathies, including valve and septal defects (Garg
et al., 2003; Rajagopal et al., 2007). However, the genetic programs
under Gata4 control are not well understood. This is a challenging
problem to address genetically, since Gata4 expression is not
restricted to a speciﬁc lineage, there is potential compensation from
co-expressed sister genes (Gata5 and Gata6), and it could potentially
function either cell-autonomous or non-cell-autonomous with re-
spect to cardiac lineages..
t.
ll rights reserved.The murine Gata4 knockout is embryonic lethal, and while there is
a heart phenotype, this is secondary due to defects in extra-embryonic
endoderm that affect embryonic folding (Kuo et al., 1997; Molkentin
et al., 1997). Gata4 deﬁcient ES cells retain the ability to differentiate
into cardiomyocytes in vitro, and the analysis of chimeric mice hosting
knockout cells proved that Gata4 is not required for cardiomyocyte
differentiation (Narita et al., 1997a). However, Gata4 does function in
cardiac cells. Conditional knockout mice, lacking Gata4 in speciﬁed
cardiomyocytes, and transgenic mice expressing only 30% of the
normal levels of GATA4 in the heart, both display atrioventricular
canal defects and a hypoplastic ventricular myocardium. The
ventricular hypoplasia is thought to be associated with defects in
cardiac morphogenesis and cardiomyocyte proliferation, rather than
differentiation (Pu et al., 2004; Zeisberg et al., 2005). Tetraploid
complementation was used to rescue the extra-embryonic defects in
Gata4 null embryos, in order to analyze the function of Gata4 during
mouse organogenesis (Watt et al., 2004). These embryos lack
proepicardium and show defects in cardiac morphogenesis, including
a hypoplastic ventricular myocardium. Likewise, we showed a
morphogenetic defect in zebraﬁsh depleted for Gata4 (Holtzinger
and Evans, 2005). Gata4 continues to be required beyond embryo-
genesis, since heterozygous mutant adult mice are hypersensitive to
pressure-induced stress overload (Bisping et al., 2006). In addition to
its requirement for epicardial and myocardial function, Gata4 is also
essential in endocardial cells for cushion EMT and valve development
(Rivera-Feliciano et al., 2006).
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However, gain-of-function experiments suggest that Gata4 encodes
sufﬁcient activity to affect cardiomyocyte fate. Forced expression of
Gata4 enhances cardiogenesis during Xenopus embryogenesis (Jiang
and Evans, 1996) or in P19 embryonal carcinoma cells (Grepin et al.,
1997). Furthermore, Gata4 expression in Xenopus ectodermal
explants is sufﬁcient to induce differentiation of cardiomyocytes,
even after initial commitment of the explants to epidermal fate
(Latinkic et al., 2003). Gata4-null ES cells generate cardiomyocytes,
yet less efﬁciently compared to wild-type cells (Narita et al., 1997a).
In the gain-of-function experiments Gata4 might direct programs
normally regulated by other GATA factors, or the sum total of GATA
factors. Regardless of the mechanism, these experiments suggest that
Gata4 is a viable candidate for enhancing cardiogenesis from a
progenitor cell population.
Cardiomyocytes are derived from mesoderm, yet their speciﬁca-
tion during early embryogenesis is dependent on inductive signals
from endoderm that develops in close association with presumptive
cardiac mesoderm (Foley et al., 2006). Thus, ablation of the anterior
endoderm in Xenopus embryos results in a loss of myocardium due
to a failure of cardiomyocyte speciﬁcation (Nascone and Mercola,
1995). Gata4 also regulates growth of endoderm-derived organs,
including gut, liver and pancreas in zebraﬁsh (Holtzinger and Evans,
2005), consistent with the analysis of knockout mice rescued by
tetraploid complementation (Watt et al., 2007). Wild-type endo-
derm is sufﬁcient to rescue cardiogenesis in both mouse (Narita et
al., 1997b) and chick (Ghatpande et al., 2000) embryos lacking
normal Gata4 expression in the mesoderm. Therefore, Gata4
functions in both mesoderm and endoderm, consistent with a role
in regulating the emerging lineages derived from a common
precursor germ-layer, referred to as the mesendoderm (Loose and
Patient, 2004).
The embryonic stem (ES) cell system provides an accessible model
to study the early stages of murine cardiomyocyte speciﬁcation, in the
context of embryoid body (EB) development. Indeed, a recent study
showed that co-culturingmurine ES cell-derived EBs with BMP2 and a
combination of visceral endoderm-like cells increases signiﬁcantly the
generation of cardiomyocytes (Bin et al., 2006). However, it is not
known if Gata4 is relevant to this or other inductive mechanisms
during cardiogenesis. An experimental challenge is the fact that Gata4
functions in both extra-embryonic and embryonic endoderm. Direct
over-expression of Gata4 in murine ES cells causes them to
differentiate into extra-embryonic endoderm (Fujikura et al., 2002;
Zhang et al., 2007), precluding investigation of function during EB
development. We therefore generated a system to conditionally
express Gata4 in cultured EBs, and evaluate its ability to direct
cardiomyocyte fate.
Material and methods
ES cell line derivation and culture
The embryonic stem cell lines AinV15 and AinV18 were described
(Kyba et al., 2002) and we used these parental ES cells (referred to
generically as AinV cells) to generate the Gata4-inducible lines (and
they functioned equivalently as controls). The iresEGFP fragment from
pIRES2EGFP (Clontech) was isolated following restriction with XhoI
and NotI and inserted into the plox vector to generate plox-iresEGFP.
A cDNA fragment encoding a ﬂag-tagged Gata4 open reading frame
(Gata4ORF) was cloned into the HindIII and XbaI sites of the KS
plasmid (Stratagene) to create KS-FLAG-Gata4ORF. The FLAG-
Gata4ORF was then inserted into the XhoI site of plox-iresEGFP
(conﬁrming the appropriate orientation). Twenty micrograms of the
resulting targeting construct (plox-FLAG-Gata4ORF-iresEGFP)was co-
electroporated with 20 μg of the pSalk-CRE expression vector into
8×106 AinV cells. Stably transfected cells were selected usingincreasing concentrations of G418 (Cellgro; up to 400 μg/ml). In
addition to harvesting pools of clones, individual clonal lines were
also selected by limiting dilution in 96-well plates. In each case,
proper integration of the transgene was conﬁrmed by PCR analysis of
genomic DNA using the following primers: fwd: 5′-CTAGATCTC-
GAAGGATCTGGAG-3′; rev: 5′-ATACTTTCTCGGCAGGAGCA-3′.
ES cells were maintained on irradiated mouse embryonic ﬁbro-
blasts (MEFs) in Dulbecco's modiﬁed Eagle medium (DMEM) supple-
mented with 20% ES-qualiﬁed fetal calf serum (Gemini), penicillin,
streptomycin, LIF (2% conditioned medium) and 1.5×10−4 M
monothioglycerol (MTG; Sigma). For the generation of embryoid
bodies, ES cells were depleted from MEFs, trypsinized and plated at
day 0 at a concentration of 12,000 cells/ml in ethylene oxide treated
dishes (VWR Scientiﬁc), in Iscove's Modiﬁed Dulbecco Medium
(IMDM) supplemented with 15% FCS (Atlas), 2 mM L-glutamine
(Gibco/BRL), 10% protein-free hybridoma medium (PFHMII; Gibco-
BRL), 0.18 mg/ml transferrin (Roche), 50 ng/ml ascorbic acid
(Sigma), 4.5×10−4 M MTG, penicillin, and streptomycin. Transgene
expression was induced by addition of doxycycline (Sigma) into the
culture media at a ﬁnal concentration of 1 μg/ml.
Western blotting
Total protein extract (20 μg) derived from embryoid bodies was
electrophoresed through a 10% NuPAGE Bis-Tris gel using the XCell
SureLock Mini-Cell system (Invitrogen) and transferred to a PVDF
nylon membrane (Biorad). For detection of Flag-tagged protein,
membranes were incubated with an anti-FLAG M2-HRP conjugated
monoclonal antibody (Sigma) at a 1:1000 dilution in blocking buffer.
For GATA4 detection, membranes were incubated with a rabbit anti-
mouse GATA4 primary antibody (Sigma) at a 1:500 dilution, and an
HRP-goat anti-rabbit secondary antibody (Biorad) at a 1:10,000
dilution in blocking buffer. Speciﬁc bands were detected using the
Western Blotting Luminol Reagent (Santa Cruz). To conﬁrm equal
loading, gels were stained in Coomassie Blue.
Gel mobility shift assays
Oligonucleotides used as probe or cold competitors were PAGE
puriﬁed. The upper strand oligomer was end-labeled with [γ-32P]ATP,
puriﬁed through a G-25 Sephadex column (Roche), and annealed to
its complementary lower strand. The competitors were prepared
identically, without labeling. The speciﬁc competitor was the
unlabeled probe. The non-speciﬁc competitor contains mutations in
the GATA-binding sites. The sequences of the top strands are as
follows: probe and speciﬁc competitor: 5′-AGCTTGCGGATAAGATAA-
GGCCGGAATTCA-3′; non-speciﬁc competitor: 5′-AGCTTGCGCTGAA-
CTGAAGGCCGGAATTCA-3′. Binding reactions and mobility shift
assays were carried out as described (Evans et al., 1988).
Differentiation assays
For evaluating cardiomyocyte differentiation, EBs were harvested
at day 6 and plated onto gelatin-coated dishes in IMDM supplemented
with 2 mM L-glutamine, 10% PFHMII, 0.18 mg/ml transferrin, 50 ng/
ml ascorbic acid, 4.5×10−4 M MTG, penicillin, and streptomycin. At
day 10, the EBs were evaluated visually in blinded samples to quantify
the number of beating clusters per total number of EBs. For titration
assays, EBs were derived from AinV and iGATA4 ESCs in the following
ratios: 1:0, 1:1, 1:3, 1:10, and 1:50. EBs were subsequently processed
as described above.
For evaluating hematopoiesis, cells were isolated from EBs at day 6
of development andwere plated at a concentration of 100,000 cells/ml
into 1% methylcellulose supplemented with 15% plasma-derived
serum (PDS; Antech), 5% PFHMII, 2 mM L-glutamine, 0.18 mg/ml
transferrin, 25 ng/ml ascorbic acid, 4.5 × 10−4 M MTG, 4 U/ml
Fig. 1. Characterization of the iGATA4 ES cell lines. (A) Cre-mediated recombination
between lox sites facilitates integration of the Gata4 cDNA into the targeting site of
parental AinV cells. The FLAG-Gata4ORF-iresEGFP transgene is ﬂanked by a lox site (left
black triangle) and a phosphoglycerokinase promoter (PGK-ATG). The target site in
AinV ES cell contains a tetracycline response element (tetOP) followed by a lox site and
a neomycin resistance gene lacking its start codon (NEO-pA). Upon site-speciﬁc
integration, the transgene is placed under control of the tetracycline response element.
Note that PGK-ATG lies in frame with NEO-pA to establish neomycin resistance. (B–E)
Representative results using a clonal iGATA4ES cell line. Essentially identical results
were obtained using pooled clones or several independent lines derived by serial
dilution cloning. (B and C) Merged 10× phase and ﬂuorescence images of uninduced
(B) and induced (C) iGATA4ES cells. GFP expression only in induced cells indicates
successful induction and non-leakiness of transgene expression. (D) Left panel:
Western blot analysis using total cell extracts from uninduced (−) or induced (+)
iGATA4ES-derived embryoid bodies. Protein detection was performed using a
monoclonal anti-FLAG antibody or an anti-GATA4 antibody, as indicated. Right panel:
Coomassie Blue staining of the western blotted gel. (E) Gel mobility shift analysis using
nuclear extracts from parental cells (AINV), or iGATA4ES cells, under uninduced (−) or
induced (+) conditions. The speciﬁc competitor (sp. u.c.) is a 20× excess of unlabeled
probe. The non-speciﬁc competitor (unsp. u.c.) is a 20× excess of unlabeled probe
containing mutations in the GATA-binding site.
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colonies were scored from blinded samples at day 11.
Flow cytometry
EBs were trypsinized and single cells were analyzed on a BD
FACSCalibur cytometer (BD Biosciences). For cell death assays, the
dissociated cells were processed with the Annexin V kit (BD
Pharmingen) according to the manufacturer's instructions. In some
experiments, ﬁxed cells were stained with anti-cardiac TroponinT
primary antibody (cTnT; NeoMarkers, Fremont, CA) and Cy3-
conjugated donkey anti-mouse IgG as secondary antibody (Jackson
ImmunoResearch) in PBS+ 5% saponin (Sigma). The number of cTnT-
positive cells and EGFP expressing cells was analyzed on a BD
FACSCalibur cytometer (BD biosciences). In some experiments EBs
were trypsinized and single cells were stained on ice with anti-epCAM
(eBioscience) and anti-DPPIV (R&D) antibodies, diluted 1:10 and
1:200, respectively, at a concentration of 1×106 cells per 100 μl
sorting buffer, consisting of 1× D-PBS, 2.5 mM EDTA, 25 mM HEPES
(pH 7), and 1% FBS. 7-AAD (BD Biosciences) was added to the sorting
buffer after washing and the cells were sorted using a FACSVantage
cell sorter (BD Biosciences). Analysis of ﬂow cytometric data was
performed using FloJo (Tree Star). For sorting assays, trypsinized cells
from induced day 4 iGATA4 EBs were sorted into six-well ultra low
cluster plates (Corning). Trypsin-dissociated cells from day 2 AinV EBs
were added at a 1:1 ratio to a ﬁnal concentration of 5×105 cells per
4 ml EB media. Reaggregated EBs were subsequently processed as
described for evaluation of cardiomyocyte differentiation.
Quantitative real-time PCR
Total RNA was isolated from EBs (Qiagen RNeasy mini kit). cDNA
synthesis was performed using the Transcriptor kit (Roche) and qPCR
completed on a Lightcycler 480 II (Roche) using the Lightcycler 480
Sybr Green Kit (Roche). Ct values were calculated using the second
derivative max algorithm and relative fold change determined using
the ΔΔCt method (Livak and Schmittgen, 2001), based on the median
value from a triplicate set. Each value was normalized to levels of
Gapdh transcripts. The primers used are listed in Supplementary
Table S1.
Results
An embryonic stem cell line allows conditional expression of Gata4
We adapted the system established by Kyba and colleagues (2002)
to generate an ES cell line in which Gata4 is placed under doxycycline-
inducible control. The parental AinV cell line expresses constitutively
the reverse (inactive) tetracycline transactivator protein from the
Rosa26 locus, and has an engineered targeting site placed upstream of
the HPRT locus that contains a tetracycline-regulated promoter. We
cloned a cDNA encoding ﬂag-tagged Gata4 into the targeting vector in
frame with a downstream IRES-EGFP sequence, which facilitates
evaluation of transgene expression by monitoring green ﬂuorescence.
Flanking the construct is a lox site and an initiator ATG that, upon
correct site-speciﬁc transgene integration, establishes neomycin
resistance to the AinV cells (Fig. 1A).
AinV cells were co-electroporated with the Gata4-IRES-Gfp
targeting vector and a Cre expression vector, and neomycin-resistant
clones were selected; PCR assays of genomic DNA conﬁrmed site-
speciﬁc integration of the transgene (data not shown). The cell lines
carrying the Flag-Gata4-IRES-Gfp transgene are referred to as
iGATA4ES cells. Transgene expression was induced by addition of
doxycycline to the culture medium and throughout this study similar
results were obtained using pooled clones, or using any of several
independent derived clonal lines. The absence of GFP expression inuninduced iGATA4ES cells shows that there is no detectable basal
(leaky) expression of the transgene (Fig. 1B) while strong GFP
expression in the cells cultured with doxycycline indicates appropri-
ate conditional expression of the transgene (Fig. 1C). Essentially all of
the iGATA4ES cells express GFP (and by inference GATA4) according
to ﬂow cytometry (N95%, data not shown). Western blotting
experiments using anti-FLAG or anti-GATA4 antibodies conﬁrmed
ectopic expression of GATA4 upon induction (Fig. 1D). We also
performed gel mobility shift assays using nuclear extracts prepared
from the parental AinV cells or iGATA4ES cells cultured under either
uninduced (control) or induced conditions (Fig. 1E). A much higher
level of binding activity is detected using nuclear extracts from
induced iGATA4ES cells. A site-speciﬁc unlabeled probe competes
effectively for the induced Gata4 activity, while a non-speciﬁc DNA
fails to compete with the labeled probe, conﬁrming that the induced
GATA4 protein binds speciﬁcally to its target DNA sequence (Fig. 1E).
We next established an assay to determine if Gata4 expression
inﬂuences ES-derived cardiogenesis during EB development. In this
assay, EBs are grown in suspension for 6 days and then plated onto
gelatin, under conditions (with serum) that are permissive for
mesoderm development, but do not enhance differentiation of cardiac
progenitors into beating cardiomyocytes. Gata4 was induced starting
at day 2 during the initial 6 days of EB development, and at day 10
cardiogenesis was assessed by counting the number of EBs that
develop with beating foci. Cardiomyocyte assays were set up in
parallel, using three different cell populations (Fig. 2). The ﬁrst group
represents a negative control consisting of EBs derived from the
Fig. 2. Experimental strategy for evaluating cell autonomy of Gata4 function within EBs. Three populations of EBs were initiated in parallel at day 0: the ﬁrst population is derived
only from AinV parental ES cells, a second is composed of an equal mixture of 50% AinV and 50% iGATA4ES cells, and a third is composed entirely of iGATA4ES cells. At day 2, EBs were
induced (+ dox) while control samples were left uninduced (− dox). At day 3, Gata4 transgene expression is monitored by observation of GFP expression (top panels: 10× phase;
bottom panels: corresponding views under ﬂuorescence). At day 6, EBs were plated onto gelatin under permissive conditions that allow differentiation (beating) of the cardiac
progenitors. At day 10, the number of EBs containing beating foci was counted for each experimental condition.
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second population of EBs is derived from an equal mixture composed
of 50% AinV cells and 50% iGATA4ES cells. The third population of EBs
is derived entirely from iGATA4ES cells. As shown in Fig. 2, when
doxycycline is added to the cultures at day 2 of EB development, at
day 3 the AinV EBs (group 1) do not express GFP. In the mixed
population (group 2), induced EBs display patches of GFP expression,
while EB cultures established with exclusively the iGATA4ES cells
(group 3) are homogeneously bright green. In the absence of
induction there is no detectable expression of GFP, indicating that
the transgene is not leaky. We predicted that if Gata4 can function in a
cell-autonomous manner to specify cardiomyocytes, doxycycline
induction should generate increased numbers of beating foci in
group 3 EBs, and this should be less efﬁcient or ineffective in the group
2 or group 1 EBs, respectively. This is not what we observed.
Gata4 is sufﬁcient to induce cardiogenesis but does so only in a
non-cell-autonomous manner
As expected, in the absence of doxycycline induction, the number
of beating EBs generated was low, and similar for each of the three
groups, regardless of the starting cell population (Fig. 3A). In addition,
induction with doxycycline had no effect on the generation of beating
foci for either group 1 (AinV cells) or group 3 (iGATA4ES cells). In fact,
group 3 (derived from 100% iGATA4ES cells) showed a consistent
decrease in beating foci to very low numbers approaching zero.
However, in the case of group 2, containing EBs derived from an equal
mixture of AinV and iGATA4ES cells, there is a signiﬁcant 5- to 6-fold
increase in the number of beating EBs (pb0.01). This result supports a
hypothesis that Gata4-expressing cells do not develop into cardio-
myocytes, but rather that they induce other ES-derived cells to a
cardiomyocyte fate. For our assay, we chose day 2 for induction since
this is the time during EB development that mesoderm is expected to
be speciﬁed toward deﬁned fates (Gadue et al., 2005). Since Gata4
appears to function non-cell-autonomously we tested a variety of
different induction times during culture of the mixed EBs. Results
from a representative experiment are shown in Fig. 3B, demonstrating
that induction at around day 2–3 is an optimal time to generate a
signiﬁcant increase in cardiomyocyte speciﬁcation. Based on the
timing (day 2–3) the results indicate that Gata4 affects cardiogenesis
at a relatively early progenitor state, for example, at the mesendo-derm or mesoderm stage, rather than later differentiation stages
when cardiomyocyte progenitors are already committed (Kattman et
al., 2007). We tested if cardiac induction was dependent on the ratio
of Gata4-expressing cells, since a non-autonomous effect would not
be expected to be strictly dependent on the number of inducing cells.
When the ratio of iGATA4ES cells present in the mixed EBs is lowered
3-fold, the level of induction is similar and signiﬁcant (Fig. 3C), and
even EB cultures with only 1/10 of the cells expressing Gata4,
although more variable, show a trend toward induction. Flow
cytometry was used to measure quantitatively the number of cardiac
TroponinT-expressing cardiomyocytes, and this conﬁrmed a cellular
increase of approximately 6-fold when Gata4 expression was induced,
and only in the mixed (group 2) EBs (Fig. 3D). The cTnT-positive cells
are GFP negative, consistent with the commitment of the parental
AinV cells in the mixed group to cardiac fate. The number of double-
positive GFP+cTNT+ cells is negligible in both uninduced and
induced EB samples.
We evaluated expression levels for markers by quantitative real-
time PCR using cDNA isolated from the mixed (group 2) control or
induced EBs, and conﬁrmed that cardiac differentiation is enhanced
by expression of Gata4 (Fig. 3E). Expression levels for cardiomyocyte
markers Mlc2A and Mlc2V are increased signiﬁcantly, but only when
Gata4 expression is induced. This also correlates with increased levels
of early cardiac commitment genes, since expression levels for
markers of the early cardiac lineage including Hand2, Mesp1, Nkx2.5,
Tbx5, and Tbx20 are all increased in the mixed (group 2) EBs upon
induction of Gata4. In total, the data indicates that Gata4 expands the
number of cells that commit to the cardiac fate.
Gata4 expression increases speciﬁcally cardiac progenitors rather than
expanding mesoderm derivatives generally
One possibility is that Gata4 expands the number of early EB
progenitors that commit to a mesoderm fate, for example, by
inﬂuencing the fate of mesendoderm in the EB cultures during the
equivalent of embryonic gastrulation. In this case, other mesoderm
derivatives besides cardiac would be expected to increase. It is well
established that in developing EBs the hemangioblast, a common
progenitor for primitive hematopoietic and vascular endothelial cells,
develops from a cell population within the mesoderm that is distinct
from the cardiovascular progenitors (Kattman et al., 2007). We
Fig. 3. Induction of Gata4 enhances cardiomyogenesis, but only in mixed EBs. Experiments were carried out as described in Fig. 2. (A) The relative percentage of EBs with beating foci
were determined from three distinct EB populations (group 1: 100% AinV; group 2: 50% AinV/50% iGATA4ES (mixed); group 3: 100% iGATA4ES) cultured with or without induction.
Gata4 induction at day 2 in mixed EBs results in a signiﬁcant increase in the number of beating EBs at day 10 (⁎pb0.01). These data represent the combined results of four
independent assays. Error bars represent the standard error of the mean. (B) Shown are results from a single but reproducible representative experiment in which mixed EBs were
either left uninduced (−Dox) or induced at different days as indicated (d1=day 1, etc.). EBs were cultured until day 6 and plated for cardiomyocyte assays and beating foci were
counted at day 10. In a reproducible manner, maximal foci are seen with induction at day 2–3. (C) Efﬁcient induction of cardiogenesis occurs over a range of iGATA4 ESC ratios. EBs
were derived from starting ratios of parental AinV and iGATA4 ESCs (AinV:GATA4, respectively), as indicated. At day 6, EBs were replated on gelatinized petri dishes in media
supporting cardiomyocyte differentiation. The resulting EB clusters were counted at day 10. Shown is the combined result of three independent experiments. ⁎pb0.006 and
⁎⁎pb0.033 when comparing day 2 uninduced (−, grey bars) to the induced (+, green bars) group using Student's T-test. Even at the 1:10 ratio there is a clear trend toward
induction, although it is more variable and did not show statistical signiﬁcance. Error bars represent the standard error of the mean. (D) Shown is a representative example of ﬂow
cytometry using a 1:1 ratio of iGATA4ES:AinV EBs that were either left uninduced (−dox) or induced at day 2. The EBs were plated at day 6, and at day 10 the EBs were harvested,
dissociated, and evaluated concurrently for GFP expression (ﬂuorescence) and cTnT expression (using intracellular antibody staining). The cTnT-positive cell population is indicated
by the block grey arrow in the+dox panel. The induced EBs show typically 10% cardiac cells (compared to 1% in control samples), although this is likely an under-estimate, since the
beating foci containing cardiomyocytes are difﬁcult to dissociate, and only single cells were counted. The GFP+ cells fall outside the cTnT gate, and the percentage of double-positive
cells in the induced samples is never above background. (E) Quantitative real-time PCR analysis for cardiac markers, as indicated, in day 6 induced mixed EBs normalized to levels in
day 6 uninduced controls. Shown are results from three independent experiments, with relative expression data log2 transformed. Error bars indicate the standard error of themean
with asterisks denoting statistical signiﬁcance (pb0.05). In other cases, a single sample gave a relatively high difference. While this limited statistical signiﬁcance, the trend for all
cardiac markers is nevertheless clear.
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the hematopoietic fate, by analyzing the ability of induced EBs to
generate differentiated primitive erythroid colonies. We compared
the three experimental groups described previously (Fig. 2) in the
presence or absence of Gata4 induction, except that at day 6 the EBs
were dissociated and progenitors were cultured for 5 days in
methylcellulose, under conditions that promote erythroid colony
development (Fig. 4). As expected, all three uninduced groups
generate a similar number of erythroid colonies, and this is equivalent
in the samples obtained from induced AinV control cells. However, the
cells plated from group 2 (mixed) EBs that had been induced to
express Gata4 generate signiﬁcantly less erythroid colonies compared
to the same samples that had been left uninduced (pb0.05). Even
more striking, the EBs derived from iGATA4ES cells (group 3) show a
major reduction in erythroid colony formation compared to any of theuninduced EBs (pb0.05). These results indicate that mesoderm in the
mixed EBs is relatively defective at hematopoietic development, due
to the presence of the Gata4-expressing cells. Since Gata4 expression
induces cardiac fate through a non-cell-autonomous mechanism, this
does not occur through an increase ofmesoderm formation, but rather
by directing speciﬁcation of early progenitors toward a cardiac fate.
Gata4 directs development of ES-derived EBs into endoderm
The ES-derived cells expressing Gata4 do not differentiate into
cardiomyocytes, yet they inﬂuence indirectly cardiomyocyte fate. We
therefore carried out marker analysis to investigate the fate of Gata4-
expressing cells in the mixed EBs. For this purpose, we separated by
FACS the GFP+ and GFP− cells from mixed EB cultures (group 2) at
day 3, following 24 h of incubation with doxycycline. These cells were
Fig. 4. Gata4-induced signals suppress hematopoietic progenitors. Erythroid colony
assays were carried out using the three different EB populations (100% AinV; 50% AinV/
50% iGATA4ES (mixed); 100% iGATA4ES) cultured with (+) or without (−) induction
by doxycycline. Gata4 induction at day 2 of iGATA4ES or mixed EBs results in a
signiﬁcant decrease in the number of primitive erythroid colonies (pb0.01 and pb0.05,
respectively). These data represent the combined results of four independent colony
assays. Error bars represent the standard error of the mean.
Fig. 6. In EBs derived entirely of iGATA4ES cells, induction of Gata4 generates Sox17+
cells and a relative loss of mesoderm. Shown are accumulated qPCR results from three
independent experiments measuring transcripts at day 3 for cells from EBs induced to
express GATA4 protein at day 2. Levels from induced EBs were compared with
uninduced controls and the relative differences are plotted with the data log2
transformed. Early mesoderm markers are repressed, while Sox17 transcript levels are
increased. Error bars indicate the standard error of the mean with asterisks denoting
statistical signiﬁcance (pb0.05).
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GFP+ cells (iGATA4ES-derived) expressed more than 50-fold and 25-
fold enhanced levels of the early endoderm markers Sox17 and Dkk1,
respectively, compared to the GFP− cells (AinV-derived). In contrast,
the iGATA4ES cells expressed dramatically reduced levels of meso-
derm markers Bry and Mesp1, and relatively reduced levels of
mesoderm markers Flk1 and Mesp2, compared to the AinV-derived
cells. These results strongly support the idea that Gata4 functions
between day 2 and day 3 in the mixed EBs to direct in a cell-
autonomous manner endoderm fate.
Gata4 was shown previously to be necessary and sufﬁcient for
visceral endoderm differentiation from murine embryonic stem cells
(Fujikura et al., 2002; Soudais et al., 1995). However, the Sox17+
endoderm generated in iGATA4 ES cells is caused by induction
starting at day 2 of EB development, when cells may be responsive to
signals that commit toward a deﬁnitive endoderm or mesoderm fate.
We therefore carried out transcript proﬁling experiments with EBs
derived entirely from iGATA4ES cells either left uninduced or inducedFig. 5. In EBs that are enhanced for cardiogenesis, the Gata4-expressing cells commit to
endoderm, not mesoderm. Shown are representative qPCR results using cDNA derived
from cells sorted out ofmixed EBs (group 2, 50% iGATA4ES/50%AinV). EBswere induced
with doxycycline at day 2, and at day 3 the GATA4-expressing cells were sorted as GFP+
and compared to levels of transcripts (as indicated) in the GFP−. The normalized
expression data is shown log2 transformed. The GATA4-expressing GFP+ cells express
relatively high levels of endodermmarkers Sox17 andDkk1, and relatively low levels for
the mesoderm markers. Multiple independent experiments gave similar results.with doxycycline at day 2. RNA was puriﬁed at day 3 from these
cultures and used to generate cDNA. The relative expression levels for
speciﬁc early markers were evaluated by quantitative real-time PCRFig. 7. Markers for both visceral and deﬁnitive endoderm are enhanced when GATA4
expression is induced at day 2 of EB development. Shown are results from three
independent experiments using three different iGATA4ES subclones. Cells were
harvested at day 6 and qPCR was performed to measure relative fold change comparing
the values from each subclone to its uninduced control, shown in the graphs with the
data log2 transformed. Top panel: A subset of deﬁned visceral endoderm markers are
increased in levels (Apoc2, Cubn), while others (Emp2, Pem1) are not. Middle panel:
Expression of pan-endoderm markers (FoxA2, FoxA3, Tspan7) are increased whereas by
day 6 Bry and Flk1 transcript levels are unchanged or downregulated. Bottom panel:
Deﬁnitive endoderm marker levels are generally increased (Cxcr4, Dlx5, FoxG1, Idb4,
Pax9, Pyy). Error bars indicate the standard error of the mean with asterisks denoting
statistical signiﬁcance (pb0.05). In some other cases, a single sample gave a relatively
high difference.While this limited statistical signiﬁcance, the trend is nevertheless clear.
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fold increase in Gata4 transcript levels. In contrast, the same induced
samples express much lower levels of transcripts for the posterior
primitive streak markers HoxB1 and Evx1, as well as the early
mesoderm markers MixL1 and Bry. Sox17 transcript levels are
substantially increased. These results conﬁrm, as shown for the
mixed cultures, that Gata4 expression directs the development of ES-
derived progenitors toward generation of endoderm and not
mesoderm.
However, a closer evaluation of endoderm markers revealed
additional complexity. Visceral and deﬁnitive endoderm lineages are
closely related and share the expression of many pan-endoderm
markers, including Sox17 and Dkk1. Several groups have sought
recently to better characterize genes that distinguish the endoderm
subtypes, through expression proﬁling of isolated embryonic endo-
derm tissues (Hou et al., 2007; Sherwood et al., 2007). We used this
information to focus on markers that should be relatively enriched in
visceral or deﬁnitive endoderm (Fig. 7). RNA was prepared from
control and induced samples at day 6 and evaluated by qPCR. The
expression levels for the visceral endoderm markers Pem and Emp2
are reduced in EBs that are induced at day 2 to express Gata4. In
contrast, the transcript levels of Apoc2 and Cubn are substantially
increased by Gata4 expression, suggesting that the iGATA4 EBs
generate a subtype of visceral endoderm. Meanwhile, deﬁnitive
endoderm markers Cxcr4, Dlx5, FoxG1, and Pax9 are all signiﬁcantly
increased, while modest increases are noted also for Idb4 and Pyy,
indicating that Gata4-expressing EBs are also directed toward a
deﬁnitive endoderm fate. Cxcr4 is a marker that clearly distinguishes
deﬁnitive endoderm from extra-embyronic endoderm (Morrison et
al., 2008; Takenaga et al., 2007).Fig. 8. GATA4 induces a mixture of visceral and deﬁnitive endoderm subtypes. (A) Shown
(visceral endoderm). (i) A representative experiment is shown of an uninduced iGATA4ES c
were harvested and analyzed at day 4 on a FACSCalibur cytometer. This experiment was repe
in the preparative sorting experiments with iGATA4 EBs induced at day 2 and dissociated a
endoderm (DE, epCAM+/Dpp4−), or visceral endoderm (VE, epCAM+/Dpp4+) and popu
populations are greater than 90% pure (not shown). (B) Shown are representative qPCR ana
data log2 transformed, compared to those in the control uninduced sample. Double negativ
markers. Right panel: Known pan and DE markers. Both deﬁnitive and visceral endoderm s
the expression of deﬁnitive endoderm (Cxcr4, Gsc) or visceral endoderm (Apoc2, Cubn) mark
double-negative sample, containing mesoderm, is also positive for Cxcr4 and Gsc. Both en
decreased levels of visceral endoderm markers Emp2 and Pem1. Equivalent results were obSince Gata4 expression appears to direct development in EBs of
both primitive and deﬁnitive endoderm, we determined if both
subtypes could be quantiﬁed by ﬂow cytometry. We used a double-
staining protocol suggested by Sherwood et al. (2007) to distinguish
the cell types. Staining for epCAM identiﬁes all embryonic endoderm
subtypes, while high levels of Dpp4 speciﬁcally characterize visceral
endoderm. As shown in a representative ﬂow experiment (Fig. 8Ai),
both endoderm subtypes are readily distinguished and increased in
numbers when iGATA4ES cells are induced to express Gata4. In EBs
induced at day 2, we reproducibly ﬁnd approximately 60% of the cells
are by day 4 epCAM+ endoderm. Approximately 50% of these
endoderm cells are Dpp4+ (visceral endoderm), with the other half
being Dpp− (deﬁnitive endoderm). When these two subtypes were
sorted (Fig. 8Aii) we could validate their character by qPCR analysis
(Fig. 8B). For example, only the double-positive cells are enriched for
Apoc2 and Cubn, the single-positive epCAM+ cells are enriched for
Cxcr4 and Gsc transcripts (compared to the double-positive cells,
but similar to the double-negative mesoderm-containing population,
as expected), while both endoderm populations are highly enriched
for pan-endoderm markers Hex, Sox17, FoxA2, FoxA3, and Tspan7.
Consistent with the whole EB samples, the double-positive cells are
not enriched for the visceral endoderm markers Emp2 or Pem.
The ability to distinguish by ﬂow cytometry distinct types of
endoderm allowed us to test their respective cardiac-inducing
activities. For this purpose, iGATA4ES cells were used to generate
EBs that were induced with doxycycline at day 2, and the day 4
epCAM+Dpp− (deﬁnitive endoderm) and epCAM+Dpp+ (visceral
endoderm) cells were puriﬁed by ﬂow cytometry. These cells were
used separately to make EBs by re-aggregation with equal numbers of
cells derived from EBs made using the parental AinV line. The re-is the ﬂow cytometry strategy, with live cells gated for epCAM (endoderm) and Dpp4
ontrol and the same cells induced to express GATA4 at day 2 of EB development. Cells
ated (n=3) with similar results using independent subclones. (ii) Gating strategy used
t day 4 of development. Cells were gated as negative (N, epCAM-/Dpp4−), deﬁnitive
lations were sorted with a BD FACSVantage cell sorter. Secondary analyses showed the
lyses to validate the sorting strategy. The relative transcript levels are plotted with the
e and VE and DE endoderm samples are labeled as in panel (Aii). Left panel: Known VE
orted cells show expression of pan-endoderm markers (FoxA2, FoxA3, Tspan7) whereas
er levels is relatively enhanced in their respective sorted populations. As expected, the
doderm subtypes demonstrate expression of the anterior endoderm marker Hex and
tained in at least three independent experiments.
Fig. 9. The bulk of the cardiogenic inducing activity fromGATA4-expressing cells is in the
visceral endoderm population. (A) Cell populations were sorted at day 4 as described in
Fig. 8 and were then mixed with dissociated cells from day 2 AinV EBs in a 1:1 ratio at a
concentration of 1.25×105 cells/ml. Reaggregated EBs were plated on gelatinized petri
dishes 4 days later in media supporting cardiomyocyte differentiation. The resulting EB
clusters were counted at day 10 (relative to the responding AinV cells). Shown are the
combined results of two independent experiments. The asterisk indicates pb0.011
when comparing AinV:VE to AinV using Student's T-test. (B) Differential expression of
cardiac-inducing molecules in the two endoderm populations. Shown are representa-
tive qPCR results using cDNA generated from sorted cell populations. Cells were derived
and sorted as described in Fig. 8, and the levels relative to uninduced controls are plotted
with the data log2 transformed. Both endoderm subtypes express enhanced levels of the
Wnt antagonistsDkk1 and Sfrp5, whereas the visceral endoderm, compared to deﬁnitive
endoderm, shows relatively increased levels of Bmp2 and Bmp6 transcripts. Equivalent
results were obtained in at least three independent experiments.
Fig. 10. Gata4 does not selectively induce apoptosis in EB cultures. EBs were generated from
were harvested at days 2.5, 3, 3.5, or 4 as indicated and dissociated, and cells were evaluated b
a representative experiment that was reproducible with equivalent results.
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development of beating foci and cardiomyocytes. As shown in Fig. 9A,
both types of endoderm had cardiac-inducing activity, but this was
low and variable in the case of the deﬁnitive endoderm. In contrast,
the bulk of the cardiac-inducing activity appears to derive from the
visceral endoderm subtype, which gave results similar to those using
unsorted iGATA4ES cells. Since the two endoderm samples are closely
related, we considered whether downstream targets regulated by
Gata4 might include secreted cardiac-inducing signaling molecules.
Preliminary microarray experiments, comparing transcript patterns
generated using cDNA from uninduced and induced iGATA4ES-
derived EBs, identiﬁed signiﬁcant increases in expression for Dkk1,
Sfrp5, Bmp2, and Bmp6 (data not shown). This was conﬁrmed
quantitatively by qPCR using independent samples that were sorted
to compare the visceral and deﬁnitive endoderm derivatives (Fig. 9B).
Both Dkk1 (Marvin et al., 2001; Schneider and Mercola, 2001) and
Sfrp5 (Finley et al., 2003) are known WNT inhibitors, and WNT
inhibition is a key step of cardiac induction. BMPs have also been
implicated upstream of a cardiac-inducing pathway (Bin et al., 2006;
Shi et al., 2000). Interestingly, we ﬁnd that both visceral and deﬁnitive
subtypes express high and similar levels of transcripts for the WNT
antagonists, while the more active (cardiac-inducing) visceral
endoderm is relatively enriched for BMP transcripts.
Gata4 expression directs the development of endoderm with
liver potential
We considered if Gata4 leads to selection of cells that are already
endoderm fated, for example, by loss of mesoderm. In this case we
would expect to see differences in cell survival in EBs induced to
express Gata4. We generated EBs using the iGATA4ES line, induced
Gata4 expression at day 2 with doxycycline, and harvested cells atthe iGATA4ES line and either left uninduced or induced at day 2 to express Gata4. EBs
y ﬂow cytometry for cell death (7-AAD) and apoptosis (Annexin V). These data are from
Fig. 11. The GATA4-expressing EBs eventually are highly enhanced for liver markers.
The EBs derived entirely from iGATA4ES cells were induced to express Gata4 at day 2,
plated at day 10 under conditions that normally support mesoderm development, and
harvested at day 17. Shown are representative qPCR results analyzing cDNA isolated
from induced EBs compared with levels of transcripts (as indicated) in the uninduced
control cells. The relative levels are plotted with the data log2 transformed. The GATA4-
expressing cells have relatively high levels of transcripts for liver markers Afp and Alb,
and relatively unchanged levels for the pancreas markers Pdx1 and Ins. Multiple
independent experiments gave equivalent results.
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by ﬂow cytometry. As shown from a representative experiment in Fig.
10, there is not a signiﬁcant change in the amount of cells that are 7-AAD
or Annexin V positive at any time point, comparing the uninduced and
induced samples. Total cell numbers in the EB cultures do not vary
signiﬁcantly in the control or doxycycline-induced conditions, and there
is no evidence of differential cell death. Since the EBs generate
considerablymore endodermthanmesoderm,Gata4 appears to actively
direct uncommitted cells toward endoderm fates.
Finally, we allowed the GATA4-expressing cells to remain in
culture to evaluate the eventual fate of the endoderm-committed
cells. The iGATA4ES-derived EBs were induced at day 2 and allowed to
develop in culture to day 17. Analysis of transcript levels by qPCR
showed that these EBs differentiate with a signiﬁcant bias toward
liver fate (Fig. 11). In contrast to day 6 EBs, these cultures no longer
show enhanced levels of visceral endoderm markers. Instead, the
transcript levels are enhanced 620-fold for Afp and 20-fold for Alb in
the induced samples compared to the uninduced control EBs. In
contrast, there was little if any relative difference in the transcript
levels for the pancreatic markers Pdx1 or Ins.
Discussion
Heart failure associatedwith the loss of contractile cardiomyocytes
is a major cause of mortality and morbidity, and strategies that
facilitate efﬁcient generation of cardiomyocytes from ES cells provide
an attractive approach for developing cell-based therapies (Chien et
al., 2008; Murry and Keller, 2008). An important goal is to identify the
appropriate molecular pathways that can enhance the speciﬁc and
efﬁcient speciﬁcation and differentiation of cardiomyocytes. We
hypothesized that Gata4 might stimulate this process, since it is an
early cardiomyocyte marker and is recognized as a key regulator of
cardiomyocyte growth and survival (Heineke et al., 2007; Liang and
Molkentin, 2002). Our results using conditional expression in an ES
cell model conﬁrm that Gata4 expression enhances signiﬁcantly the
commitment of progenitor cells to a cardiomyocyte fate. However, we
found that the mechanism is indirect, and Gata4 induces cardiomyo-
cyte differentiation in a non-cell-autonomous manner. The study
suggests that Gata4 directs expression of target genes, including Dkk1
and Bmp6 encoding secreted factors with the potential to stimulate
cardiogenesis.
A role for GATA factors in regulating endoderm development
reﬂects an evolutionarily conserved pathway. GATA factors are
essential for endoderm speciﬁcation in worms and ﬂies (Maduroand Rothman, 2002; Murakami et al., 2005), and ectopic expression of
the C. elegans or Drosophila endodermal Gata genes induces endoderm
development in Xenopus ectoderm explants (Murakami et al., 2005;
Shoichet et al., 2000). Similarly, Xenopus Gata4 regulates gut-speciﬁc
genes (Gao et al., 1998) and induces endoderm gene expression in
ectoderm explants (Afouda et al., 2005). Embryonic explant assays
implicated anterior endoderm as a tissue from which cardiac
inductive cues are derived, including members of the NODAL, BMP,
FGF and WNT signaling pathways (for review, see Lough and Sugi,
2000). Explant assays in Xenopus identiﬁed DKK1 as a secreted factor
required for expression of Hex1 in endoderm associated with
presumptive cardiac mesoderm (Foley et al., 2006). Consistent with
these data, the ES-derived cardiac-inducing cells speciﬁed by Gata4
express and secrete high levels of antagonists for canonical WNT/
beta-catenin signaling, speciﬁcally Dkk1 and Sfrp5. Using ELISA assays,
the culture medium from day 6 induced EBs derived from iGATA4ES
cells was shown to contain approximately 14-fold the levels of DKK1
compared to medium from sister EBs that were not induced (not
shown). We attempted to evaluate the ability of conditioned medium
from the iGATA4ES cells to induce cardiogenesis, and the necessity of
Dkk1 for cardiac induction in the EB system using DKK1-speciﬁc
blocking antibodies, but in both cases the results were equivocal,
possibly for technical reasons related to reagent penetrance, or
because of variable compensation from other antagonists (e.g., Sfrp5)
or factors (e.g., Bmp6). While Gata4 clearly functions non-cell-
autonomously, we do not know if the secreted factors function to
regulate the Gata4-induced endoderm in a paracrine fashion, as
suggested by Xenopus endoderm studies (Foley et al., 2006). We
established cultures with iGATA4ES EBs separated by transwell ﬁlters
from EBs derived from parental AinV ES cells. When induced with
doxycycline the transwell cultures failed to demonstrate signiﬁcant
induction of cardiogenesis. Together, these negative results suggest
that Gata4-induced signals may be complex and/or function by a
juxtaparacrinemechanism during EB development. Forced expression
of a cardiac mesoderm speciﬁcation gene, MesP1, is sufﬁcient to
induce cardiac fate, by a DKK1-mediated pathway (David et al., 2008).
Therefore, it is possible that bothmesoderm and endoderm associated
with the presumptive cardiac region integrate cardiac induction using
common signals. Expression of Gata4 in the mixed EBs is sufﬁcient to
drive transcript levels for Dkk1, Hex, and MesP1.
The timing of WNT antagonism is of critical importance to
regulating cardiogenesis (Eisenberg and Eisenberg, 2006). The ES
cell/embryoid body system is proving useful for dissecting this
problem in the mouse, given the spatio-temporal complexity of the
early embryo, and since the expression of key regulatory genes can be
directed with temporal speciﬁcity. With respect to WNT signaling,
early canonical WNT signals are essential for generation of Flk1+
mesoderm, including presumptive cardiac mesoderm, so that appli-
cation of DKK1 from the earliest stages blocks expression of Gata4
(Lindsley et al., 2006). Using conditional expression of WNT pathway
modulators in zebraﬁsh, WNT signaling prior to gastrulation was
shown to promote cardiac fate, while later signaling during
gastrulation represses heart formation (Ueno et al., 2007). In our EB
assay, induction of Gata4 expression around day 2–3 is optimal for
inducing cardiogenesis. While this is a relatively early time point, the
subsequent accumulation of functional WNT antagonists (requiring
target gene transcription, translation, secretion, etc.) around day 4–6
is more consistent with the later (post-gastrulation) requirement to
inhibit WNT signaling. Importantly, the comparison of visceral and
deﬁnitive endoderm subtypes at day 4 of EB development suggests
that WNT antagonism expression is not sufﬁcient for efﬁcient
induction, and implies that another, perhaps earlier signal (for
example, BMP-mediated) integrates with subsequentWNT inhibition.
Other factors, yet to be identiﬁed, may also be required.
Continued WNT signaling (along with VEGF) directs mesoderm
toward a hematopoietic fate (Nostro et al., 2008). Our data suggests
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endoderm fate, even under culture conditions that normally support
mesoderm at the expense of endoderm development (Kubo et al.,
2004). During mesoderm development in our mixed EB cultures,
factors induced by Gata4 commit cells toward a cardiac fate, since
timed expression of Gata4 is sufﬁcient to enhance cardiomyocyte fate
while at the same time repressing the hematopoietic program. BMP
signaling enhances hematopoiesis, so that the repression of hemato-
poietic fate could be mediated by suppression of WNT signaling.
Experiments in Xenopus and ES cell models implicateWnt11 as a non-
canonical signal that is required subsequently for promoting
cardiogenesis (Afouda et al., 2008; Ueno et al., 2007).
Inhibition of the endoderm speciﬁcation gene Sox17 in ES cells by
RNA interference results in suppression of cardiomyocyte differentia-
tion, without altering mesoderm formation. Sox17 induces cardiomyo-
genesis in a non-cell-autonomous manner through the endodermal
cardiogenic factor Hex (Liu et al., 2007), consistent with the Xenopus
studies ofMercola and colleagues. In the Sox17 study, the levels ofGata4
werenot affectedby the lack of Sox17. On the other hand, inducedGata4
expression in our EB system increases signiﬁcantly the levels of Sox17
and Hex. Therefore, our results indicate that Gata4 acts upstream of
Sox17 for the production of endoderm-derived heart-inducing factors.
It should be noted that Gata4 does not function only in the endoderm.
Embryo-proper and cardiac conditional knockout experiments have
clearly demonstrated Gata4 functions for proliferation and survival of
cardiomyocytes (see Introduction). While the function in mixed EB
cultures for Gata4 is for development of cardiac-inducing endoderm, it
remains to be known if Gata4 in the mesoderm cells regulates the
response to endoderm-derived cardiac-inducing signals. Forced expres-
sion ofGata4 directly in embryonicmesoderm is not sufﬁcient to induce
cardiac fate, but does promote cardiac speciﬁcation and differentiation
when co-expressed in non-cardiac mesoderm with Tbx5 and Baf60c
(Takeuchi and Bruneau, 2009).
In summary, our data show that Gata4 expression is sufﬁcient to
specify cardiomyocyte fate in ES cell-derived progenitors, although it
does so by an indirect mechanism. Rather than directing mesoderm
toward a cardiac fate, Gata4 (even when expressed during EB cultures
that promote mesoderm) directs the development of cardiac-
inducing visceral endoderm and deﬁnitive endodermwith hepatocyte
potential. Recent lineage tracing experiments in the mouse showed,
contrary to previous dogma, that visceral endoderm incorporates
extensively into the epiblast-derived deﬁnitive endoderm and
incorporates into the developing gut tube (Kwon et al., 2008). It will
be interesting to know if the visceral endoderm subtype generated by
Gata4 in EBs relates to this process. We note that forced expression of
Gata4 in EB cultures could alter the normal kinetics of cell
speciﬁcation, proliferation and/or differentiation, and it is therefore
possible that Gata4 does not normally function in this manner. The
current study is purposefully meant to explore “functional capability”
rather than normal development. Yet since Gata4 is expressed in
visceral and deﬁnitive presumptive foregut endoderm, and in the
associated cardiogenic mesoderm, it may play a central role through
co-regulating both the character of cardiac-associated inductive
endoderm, and the cardiac mesoderm itself. This would permit the
appropriate spatial and temporal presentation of BMPs, WNT
antagonists and other signals to promote cardiomyocyte development
at the right time and place. In addition to the developmental relevance
of this study, we established an assay to identify additional Gata4-
dependent factors that can impact the generation of cardiomyocytes
and possibly hepatocytes from ES cells.
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